New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
09:13 EDTCLRXCollabRx and CellNetix Pathology & Laboratories sign agreement
CollabRx and CellNetix Pathology & Laboratories announced a multi-year agreement to access CollabRx technology and content resources in support of the clinical interpretation of genetic sequencing-based tests provided by CellNetix. Under the terms of the agreement, CollabRx medical and scientific knowledge will be incorporated into the results of genetic sequencing-based tests in oncology provided by CellNetix. CellNetix will leverage CollabRx's knowledgebase in molecular medicine.
News For CLRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
09:18 EDTCLRXOn The Fly: Pre-market Movers
Subscribe for More Information
07:02 EDTCLRXCollabRx, Medytox sign definitive merger agreement
Subscribe for More Information
April 7, 2015
15:03 EDTCLRXCollabRx appoints Smruti Vidwans as Chief Science Officer
In a regulatory filing, CollabRx reports that on April 2, Smruti Vidwans, currently Chief Scientist, was appointed the company's Chief Science Officer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use